AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
The Pharmaceutical Rivalry Behind the Weight-Loss Drug Boom
Big Take
The Pharmaceutical Rivalry and the Impact of Innovation on Weight-Loss Drugs
This chapter explores the advantages of being the first drug manufacturer to market and discusses the differences between Zepbound, Ozepic, and Wigovii in terms of weight loss percentages. It also mentions Eli Lilly's plans to develop a drug that combines three different gut hormones and discusses the potential impact on stock value and expectations of becoming a trillion dollar drug company.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode